|
|
1400: Impact of glycosylation on the CAR T response |
|
21 January |
13:30
13:45
|
SC Papendal
Room 6/7
|
|
|
|
1401: CDK4/6 degradation improves the manufacturing of CAR T cells with enhanced fitness |
|
21 January |
13:45
14:00
|
SC Papendal
Room 6/7
|
|
|
|
1423: Nanobody-based B7-H3 CAR T-cells for paediatric brain tumours |
|
21 January |
14:00
14:15
|
SC Papendal
Room 6/7
|
|
|
|
1409: A clinically-compatible, scalable method to generate TCR/CAR T cells from induced pluripot |
|
21 January |
14:15
14:30
|
SC Papendal
Room 6/7
|
|